ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · IEX Real-Time Price · USD
6.16
+0.18 (3.01%)
At close: Apr 16, 2024, 4:00 PM
6.11
-0.05 (-0.81%)
After-hours: Apr 16, 2024, 7:56 PM EDT

ADMA Biologics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for ADMA Biologics stock have an average target of 7.88, with a low estimate of 6.00 and a high estimate of 10. The average target predicts an increase of 27.92% from the current stock price of 6.16.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $6.00 $7.88 $8.00 $10
Change -2.60% +27.92% +29.87% +62.34%

Analyst Ratings

The average analyst rating for ADMA Biologics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '23Dec '23Jan '24Feb '24Mar '24Apr '24
Strong Buy 223333
Buy 111111
Hold 000000
Sell 000000
Strong Sell 000000
Total 334444

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$6$7.5
Strong Buy Reiterates $6$7.5 +21.75% Mar 26, 2024
Mizuho
Mizuho
Strong Buy
Maintains
$9$10
Strong Buy Maintains $9$10 +62.34% Mar 1, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
$6.5$8
Buy Maintains $6.5$8 +29.87% Feb 29, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$6
Strong Buy Reiterates $6 -2.60% Feb 29, 2024
Mizuho
Mizuho
Strong Buy
Maintains
$7$9
Strong Buy Maintains $7$9 +46.10% Jan 22, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
340.55M
from 258.22M
Increased by 31.89%
Revenue Next Year
397.67M
from 340.55M
Increased by 16.77%
EPS This Year
0.30
from -0.13
EPS Next Year
0.51
from 0.30
Increased by 68.91%
Year 2019202020212022202320242025202620272028
Revenue
29.35M42.22M80.94M154.08M258.22M340.55M397.67M440.91M406.16M431.36M
Revenue Growth
72.79%43.85%91.72%90.36%67.59%31.89%16.77%10.87%-7.88%6.20%
EPS
-0.89-0.88-0.51-0.33-0.130.300.510.600.520.56
EPS Growth
------68.91%17.41%-13.56%7.84%
No. Analysts -----66533
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 353.9M 415.3M 475.7M 444.1M 484.2M
Avg 340.6M 397.7M 440.9M 406.2M 431.4M
Low 325.3M 375.8M 393.1M 366.0M 377.0M

Revenue Growth

Revenue Growth 20242025202620272028
High
37.0%
21.9%
19.6%
0.7%
19.2%
Avg
31.9%
16.8%
10.9%
-7.9%
6.2%
Low
26.0%
10.4%
-1.2%
-17.0%
-7.2%

EPS Forecast

EPS 20242025202620272028
High 0.34 0.54 0.71 0.54 0.58
Avg 0.30 0.51 0.60 0.52 0.56
Low 0.27 0.47 0.50 0.50 0.54

EPS Growth

EPS Growth 20242025202620272028
High -
76.5%
39.3%
-11.0%
11.0%
Avg -
68.9%
17.4%
-13.6%
7.8%
Low -
55.0%
-2.5%
-16.9%
3.6%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.